Prostate Cancer
Reirradiation salvage radiotherapy for recurrent prostate cancer after primary low-dose brachytherapy.
September 8, 2023
IGF-1 axis changes with ADT and docetaxel in metastatic prostate cancer.
September 8, 2023
The biology behind combining poly [ADP ribose] polymerase and androgen receptor inhibition for metastatic castration-resistant prostate cancer.
September 8, 2023
Master transcription factor reprograming unleashes selective translation promoting castration resistance and immune evasion in lethal prostate cancer.
September 8, 2023
Molecular features of prostate cancer post-neoadjuvant therapy in the Phase 3 CALGB 90203 trial.
September 8, 2023
Quality rectal hydrogel placement allows for gel-enabled dose-escalated EBRT (GEDE-EBRT) without rectal interference in prostate cancer.
September 7, 2023
Image-guided radiation therapy produces lower acute and chronic gastrointestinal and genitourinary toxicity in prostate cancer patients.
September 7, 2023
JNM Publishes Consensus Statement on Patient Selection and Appropriate Use of Lu-177 PSMA-617 Radionuclide Therapy
September 6, 2023
Prostate cancer-multiparametric MRI and alternative approaches in intervention and therapy planning.
September 6, 2023
Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression.
September 6, 2023
Emerging role of miRNA in prostate cancer: A future era of diagnostic and therapeutics.
September 6, 2023
Androgen deprivation therapy in localized prostate cancer. Current status and future trends.
September 6, 2023
SpaceOAR hydrogel distribution and early complications in patients undergoing radiation therapy for prostate cancer.
September 5, 2023
Barrigel Spacer Injection Technique.
September 5, 2023